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Research Concentration of acrylamide in a polyacrylamide 
gel affects VP4 gene coding assignment of group A 
equine rotavirus strains with P[12] specificity
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Abstract
Background: It is universally acknowledged that genome segment 4 of group A rotavirus, the major etiologic agent of 
severe diarrhea in infants and neonatal farm animals, encodes outer capsid neutralization and protective antigen VP4.
Results: To determine which genome segment of three group A equine rotavirus strains (H-2, FI-14 and FI-23) with 
P[12] specificity encodes the VP4, we analyzed dsRNAs of strains H-2, FI-14 and FI-23 as well as their reassortants by 
polyacrylamide gel electrophoresis (PAGE) at varying concentrations of acrylamide. The relative position of the VP4 
gene of the three equine P[12] strains varied (either genome segment 3 or 4) depending upon the concentration of 
acrylamide. The VP4 gene bearing P[3], P[4], P[6], P[7], P[8] or P[18] specificity did not exhibit this phenomenon when 
the PAGE running conditions were varied.
Conclusions: The concentration of acrylamide in a PAGE gel affected VP4 gene coding assignment of equine rotavirus 
strains bearing P[12] specificity.
Background
Diarrheal disease is one of the principal causes of mor-
bidity and mortality among young children in the devel-
oping world. Infectious diarrhea of neonatal animals is
also one of the most common and economically devastat-
ing conditions encountered in the animal agriculture
industry. Among an array of infectious agents including
bacteria, viruses and parasites, group A rotaviruses are
the single most important etiologic agents of diarrhea in
infants and young children worldwide and in addition,
they are the most commonly identified viral cause of diar-
rhea in neonatal food animals [1-4]. In 1975, rotaviruses
were first demonstrated being involved in foal diarrhea
[5], and later established as the major cause of diarrhea in
young foals [6-8].
The genome of group A rotavirus, a member of Reoviri-
dae  f a m i l y ,  c o n s i s t s  o f  e l e v e n  s e g m e n t s  o f  d o u b l e -
stranded RNA numbered 1-11 according to their order of
migration in polyacrylamide gels, segment 1 being the
slowest and segment 11 the fastest [9]. The rotavirus
genome encodes six structural (VP1-VP4, VP6 and VP7)
and six nonstructural (NSP1-NSP6) proteins [3]. Since
two outer capsid proteins VP7 and VP4 are independent
neutralization and protective antigens, a binary system of
classification and nomenclature to designate the two neu-
tralization specificities has been adopted: VP7 or G
(because VP7 is a glycoprotein) serotype and VP4 or P
(because VP4 is protease-sensitive) serotype [3]. Since (i)
antibodies to the VP7 and VP4 have been demonstrated
to confer resistance to virulent rotavirus in a type-specific
manner in experimental animals; and (ii) observations
made in various rotavirus vaccine trials have suggested
that the induction of serotype-specific immunity may be
important for optimal protection, serotypic-genotypic
analyses of the VP7 and VP4 of a rotavirus derived from
various animal species have been performed [3,10,11].
Such studies have established at least 14 G serotypes (21
G genotypes) and 14 P serotypes (29 P genotypes) [12].
Among equine rotaviruses, five G types (G3, G5, G10,
G13 and G14) and three P types (P[7], P[12] and P[18])
have been identified.
In general, each rotavirus strain displays a dsRNA
migration pattern (electropherotype) on polyacrylamide
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gels distinct from that of other strains [9,13]. Hence anal-
ysis of such genomic polymorphism as determined by
polyacrylamide gel electrophoresis (PAGE) as well as
gene sequencing have been routinely used for gene cod-
ing assignments. Such studies have established that the
VP7 protein is encoded by genome segment 7, 8 or 9
depending upon the rotavirus strain. For example, the
VP7 is encoded by the 7th segment of rhesus rotavirus
MMU18006 strain in a 12% gel [14], the 8th segment of
human rotavirus DS-1 strain in a 7.5% gel [15], and the 9th
segment of human rotavirus Wa strain in a 12% gel [16].
With regard to the VP4 protein, on the other hand, it is
universally acknowledged that it is encoded by the
genome segment 4 regardless of the rotavirus strain. Dur-
ing the course of generating various single gene substitu-
tion reassortants and hyperimmune antisera to them in
an attempt to characterize and establish VP4 serotypes of
selected equine rotaviruses [17], we found unexpectedly
that the VP4 gene of equine rotavirus strains H-2, FI-14
and FI-23 was not the fourth segment but the third seg-
ment as determined by a standard 12% PAGE.
Results and discussion
Concentration of acrylamide affects the relative position of 
VP4 gene of equine rotavirus strains H-2, FI-14 and FI-23 in 
a PAGE gel
During the characterization by a standard 12% PAGE gel
analysis of selected equine-human rotavirus reassortants
that were generated between equine rotavirus (strain H-2
[18], FI-14 [19] or FI-23 [20]) and human rotavirus (strain
DS-1 [21]), we noticed that the VP4-encoding gene of
each of the three equine rotavirus strains was at the third
position (Figure 1). This was unexpected since the fourth
genome segment was the VP4-encoding gene of human
rotavirus strains Wa (P[8]) [21], DS-1 (P[4]), ST3 (P[6])
[22] as well as rhesus rotavirus strain MMU18006 (P[3])
[23] under the same PAGE running condition. Since we
reported previously that the acrylamide concentration in
a PAGE gel affected the relative position of the VP7 gene
of G2 rotavirus strains [24], we analyzed the effects of
acrylamide concentration by using H-2 strain and its
reassortant rotavirus strain. The VP4 gene of the H-2
strain was in the 4th position in a 5% (not shown) or 7.5%
(Figure 2) gel, the 3rd or 4th poison in a 10% (Figure 3) gel,
however, it was in the 3rd position in a 12% (Figure 1) or
15% (Figure 4) gel. These findings demonstrated that the
H-2 VP4 gene "flipped over" (i.e., the H-2 VP4 gene
shifted to the 3rd position from its previous 4th position)
in a PAGE gel containing acrylamide concentration
between 7.5% and 12% (Table 1). Similarly, the FI-14 and
FI-23 VP4 genes exhibited the "flip over" phenomenon
between a 7.5% gel and a 12% gel (not shown, summa-
rized in Table 1). Thus, we demonstrated that the concen-
tration of acrylamide played a critical role in determining
the VP4 gene coding assignment of equine rotavirus
strains H-2, FI-14 and FI-23. As we reported previously,
the different PAGE running conditions affected not only
the VP4 gene but also other genes as well. For example,
although segments 2 and 3 of the DS-1 strain comigrated
in a 7.5% gel (Figure 2), they were well separated in a 15%
gel (Figure 4).
VP4 gene encoding P[12] specificity appeared to be 
affected most by the concentration of acrylamide in a PAGE 
gel
Next, we investigated whether the "flip-over" phenome-
non was unique to P[12] equine rotavirus strains or com-
mon to any equine rotavirus strains. Previously [24], we
showed that the VP4 gene of human rotavirus strains Wa
(P[8]), DS-1 (P[4]), ST3 (P[6]) or rhesus rotavirus strain
MMU18006 (P[3]) was at the 4th position regardless of
acrylamide concentration in a PAGE gel (Table 1). We
found in this study that the relative position of the VP4
gene of equine rotavirus strain H-1 [25] with P[7] speci-
ficity and strain L338 [26] with P[18] specificity was not
affected by the varying concentration of acrylamide in a
PAGE gel (data not shown, summarized in Table 1). Thus,
the "flip-over" phenomenon of the VP4 gene observed in
the present study appeared to be unique to equine rotavi-
rus VP4 genes bearing P[12] specificity.
The mechanisms underlying this "flip-over" phenome-
non displayed by the VP4 gene with P[12] specificity are
unknown. Since the observed VP4 gene migration shift
appears to be a function of acrylamide concentration (all
other factors being equal), this would indicate the size of
the pores in the gel is what is generating the shift. This
argues for the shift being the result of a change in the ter-
tiary structure of the molecule. Unfortunately, tools do
not exist at present for predicting secondary or tertiary
structures for double-stranded nucleic acid sequences.
We analyzed predicted secondary structures of single-
stranded RNA of VP4 gene of selected rotavirus strains
including equine rotavirus strains with P[12] specificity,
however, we did not find any predicted structures that
were different between the equine VP4 sequences and the
others (data not shown). In addition, we examined the
VP4 sequences of selected rotavirus strains to look for
potential changes in the equine VP4 sequence that might
induce some sort of "pairing" of the ends of the molecule,
however, we did not find any good candidate sequences.
Conclusions
The relative position of the VP4 gene of three equine
P[12] strains (H-2, FI-14, FI-23) varied (either genome
segment 3 or 4) depending upon the concentration of
acrylamide. The VP4 gene bearing P[3], P[4], P[6], P[7],Long-Croal et al. Virology Journal 2010, 7:136
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P[8] or P[18] did not exhibit this phenomenon when the
PAGE running conditions were varied. Caution needs to
be exercised when PAGE analyses are used for VP4 gene
coding assignment of rotaviruses.
Methods
Rotavirus strains, cell culture, and genetic reassortment
Table 1 summarizes group A human and animal rotavirus
strains that were employed in this study. Each of the rota-
virus strains used was plaque purified three times prior to
use. Reassortant rotaviruses between equine rotavirus
strain H-2, FI-14 or FI-23 and human rotavirus strain DS-
1 were constructed by a procedure described previously
[27]. Briefly , roller tube cultures of monkey kidney cell
line MA104 were coinfected at a multiplicity of infection
of approximately one with the H-2 strain, FI-14 strain or
FI-23 strain and the DS-1 strain. When approximately
75% of the infected cells displayed cytopathic effects, the
cultures were frozen and thawed once and the lysate was
plated on MA104 cells in a six-well plate (Costar, Corning
Inc., Corning, NY) in the presence of G serotype cross-
reactive neutralizing monoclonal antibody 57/8 [20] for
selection of the desired H-2 × DS-1 and FI-14 × DS-1 and
FI-23 × DS-1 reassortants. A plaque displaying a desired
gene constellation (i.e., VP4 gene from the H-2, FI-14 or
FI-23 strain and the VP7 gene from the DS-1 strain) was
plaque purified three times prior to use. Reassortant rota-
viruses between equine rotavirus strain H-1 or strain
L338 and human rotavirus strain DS-1 were generated in
a similar manner except that polyclonal antibodies raised
against (i) porcine rotavirus OSU (P[7]G5) strain was
used for selection of H-1 × DS-1 (P[7]G2) reassortant and
(ii) L338 (P[18]G13) strain was used for selection of L338
× DS-1 (P[18]G2) reassortant. Eagle's minimum essential
medium supplemented with 0.5 μg/ml trypsin (Sigma
type IX trypsin, Sigma Chemical, St. Louis, MO) and
antibiotics was used as maintenance medium and Leibo-
vitz L-15 medium supplemented with antibiotics was
Table 1: The concentration of acrylamide affects VP4-gene coding assignment of group A equine rotavirus strains H-2, FI-
14, and FI-23 bearing P[12] specificity.
Rotavirus Species of 
origin
VP4-gene coding assignment in a PAGE gel 
containing acrylamide at indicated concentration
Strain [ref.] P (VP4)type G (VP7)type 5% 7.5% 10% 12% 15%
H-2 [18] P[12] G3 horse 4 4 3 or 4 3 3
FI-14 [19] P[12] G3 horse NDa 4N D3 N D
FI-23 [20] P[12] G14 horse ND 4 ND 3 ND
H-1 [25] P[7] G5 horse 4 4 4 4 4
L338 [26] P[18] G13 horse 4 4 4 4 4
Wa [21] P[8] G1 human 4 4 4 4 4
DS-1 [21] P[4] G2 human 4 4 4 4 4
ST3 [22] P[6] G4 human 4 4 4 4 4
MMU18006 [23] P[3] G3 rhesus 4 4 4 4 4
aND = not done
Figure 1 Electrophoretic migration patterns in a 12% PAGE gel of 
equine rotavirus H-2 strain, H-2 × DS-1 reassortant, and human 
rotavirus DS-1 strain; equine rotavirus FI-14 strain, FI-14 × DS-1 
reassortant and DS-1 strain; and equine rotavirus FI-23 strain, FI-
23 × DS-1 reassortant, and DS-1 strain. Arrows indicate the VP4 
gene (3rd genome segment) of each of the 3 equine parental rotavirus 
strains.Long-Croal et al. Virology Journal 2010, 7:136
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Figure 2 Electrophoretic migration patterns in a 7.5% PAGE gel 
of equine rotavirus H-2 strain, H-2 × DS-1 reassortant and human 
rotavirus DS-1 strain. Arrow indicates the VP4 gene (4th genome seg-
ment) of the H-2 strain.
Figure 3 Electrophoretic migration patterns in a 10% PAGE gel of 
equine rotavirus H-2 strain, H-2 × DS-1 reassortant and human ro-
tavirus DS-1 strain. Arrow indicates the VP4 gene of the H-2 strain. 
Note the 3rd and 4th genome segments of the H-2 strain comigrate.Long-Croal et al. Virology Journal 2010, 7:136
http://www.virologyj.com/content/7/1/136
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employed when making virus dilutions. Agarose (SeaKem
ME, BME, Rockland, ME) was used as a solidifying
reagent in the overlay medium.
Rotavirus RNA extraction and PAGE analysis
The standard phenol-chloroform method or TRIzol
method was employed to extract rotavirus genomic
dsRNA as previously reported [28,29]. Analysis of rotavi-
rus dsRNA was carried out at room temperature (approx-
imately 26°C) in a discontinuous 5%, 7.5%, 10% 12% or
15%, acrylamide resolving slab gel (acrylamide:bisacryl-
amide 29:1, Bio-Rad Laboratories, Hercules, CA. 18 × 16
× 0.075 cm) with a 3.5% acrylamide stacking gel in the
buffer system of Laemmli [30] without SDS using a SE600
gel apparatus (Amersham Biosciences, San Francisco,
CA) and Tris-Glycine running buffer (pH 8.3) (Bio-Rad
Laboratories). Since the polymerization temperature of
acrylamide/bisacrylamide gels has been reported to affect
the tertiary structure of the gel thereby influencing elec-
trophoretic mobilities of selected RNA species [31], the
polymerization of the PAGE gels used in this study was
performed at a single temperature of 37°C in an incuba-
tor. In addition, since heat generated during electropho-
resis has been reported to affect the mobilities of
rotavirus genomic dsRNA [32], a water chiller (Lauda
WKL230, Brinkmann Instruments, Westbury, NY) was
used, if necessary, to maintain the desired temperature of
running buffer especially when evaluating a gel with a
high percentage of acrylamide/bisacrylamide. After elec-
trophoresis, viral RNA bands were visualized by staining
of the gel with silver nitrate [33].
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